Results
Hikal Q1 FY27 Revenue Up 6.2% with 9.2% EBITDA Margin
Hikal reported Q1 FY27 consolidated revenue of ₹403 Cr, a 6.2% YoY growth, with EBITDA margin expanding 260 bps to 9.2%.
Pharmaceutical business revenue grew 15.2% YoY to ₹233 Cr, while Crop Protectio
